Physician profile
Andrew Maley
NPI 1619280674
$950.87
in general payments reported to CMS, 2019-2025
19 companies · $32.36 in 2025
The $32.36 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $60.01 · 2021: $149 · 2022: $172 · 2023: $117 · 2024: $150 · 2025: $32.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $298.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $250.07 | 2021-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Pfizer INC. | $169.40 | 2019-2025 | |
| Abbvie INC. | $104.95 | 2019-2022 | |
| Glaxosmithkline, LLC. | $62.81 | 2019-2022 | |
| Amgen INC. | $60.19 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $45.08 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $39.78 | 2021 | |
| Sanofi-Aventis U.S. LLC | $28.40 | 2019-2021 | |
| Novo Nordisk INC | $28.28 | 2019-2022 | |
| Lilly USA, LLC | $25.14 | 2019 | |
| Amarin Pharma, INC. | $22.34 | 2021 | |
| Gilead Sciences, INC. | $18.79 | 2020 | |
| Exact Sciences Corporation | $18.08 | 2024 | Cologuard Collection Kit |
| Astellas Pharma US INC | $16.16 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $13.53 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $12.65 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.57 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.60 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Maley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.